(NASDAQ: TNDM) Tandem Diabetes Care's forecast annual revenue growth rate of 6.15% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.78%.
Tandem Diabetes Care's revenue in 2025 is $1,001,719,000.On average, 6 Wall Street analysts forecast TNDM's revenue for 2025 to be $67,573,592,738, with the lowest TNDM revenue forecast at $67,393,790,375, and the highest TNDM revenue forecast at $67,866,776,672. On average, 7 Wall Street analysts forecast TNDM's revenue for 2026 to be $74,294,255,032, with the lowest TNDM revenue forecast at $71,627,017,734, and the highest TNDM revenue forecast at $77,502,183,237.
In 2027, TNDM is forecast to generate $80,934,644,794 in revenue, with the lowest revenue forecast at $77,145,416,430 and the highest revenue forecast at $86,151,075,525.